Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Boucher

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Menopause (New York, N.Y.)|March 14, 2018
Tissue selective estrogen complex (TSEC): a reviewJames H Pickar, Matthieu Boucher, Diana Morgenstern
CNS Spectrums|November 16, 2017
Categorical improvement in functional impairment in depressed patients treated with desvenlafaxineClaudio N Soares, Min Zhang, Matthieu Boucher
Journal of Clinical Psychopharmacology|February 2, 2017
Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at BaselineDaniel Mosca, Min Zhang, Rita Prieto, et al.
CNS Spectrums|May 8, 2019
Predictors of functional response and remission with desvenlafaxine 50 mg and 100 mg: a pooled analysis of randomized, placebo-controlled studies in patients with major depressive disorderClaudio N Soares, Dalia B Wajsbrot, Matthieu Boucher
European Journal of Pharmacology|July 14, 2004
Alterations of beta-adrenoceptor responsiveness in postischemic myocardium after 72 h of reperfusionMatthieu Boucher, Satra Nim, Chantal de Montigny, et al.
BMC Psychiatry|November 13, 2024
Long-term effectiveness of aripiprazole once monthly on functioning and quality of life in schizophrenia: results of year 2 of the ReLiAM studyMarc-André Roy, François Therrien, Matthieu Boucher, et al.
BMC Psychiatry|December 9, 2022
Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use - a post hoc analysis of the ReLiAM studyHoward C Margolese, Matthieu Boucher, Francois Therrien, et al.
Journal of Cardiac Failure|July 3, 2007
Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapySven T Pleger, Matthieu Boucher, Patrick Most, et al.
International Journal of Psychiatry in Clinical Practice|February 9, 2019
Switching medication products during the treatment of psychiatric illnessPierre Blier, Howard C Margolese, E Adriana Wilson, et al.
Journal of Psychopharmacology (Oxford, England)|January 9, 2020
Effects of desvenlafaxine versus placebo on MDD symptom clusters: A pooled analysisMartin A Katzman, Xuemei Wang, Dalia B Wajsbrot, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Menopause (New York, N.Y.)|March 14, 2018
Tissue selective estrogen complex (TSEC): a reviewJames H Pickar, Matthieu Boucher, Diana Morgenstern
CNS Spectrums|November 16, 2017
Categorical improvement in functional impairment in depressed patients treated with desvenlafaxineClaudio N Soares, Min Zhang, Matthieu Boucher
Journal of Clinical Psychopharmacology|February 2, 2017
Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at BaselineDaniel Mosca, Min Zhang, Rita Prieto, et al.
CNS Spectrums|May 8, 2019
Predictors of functional response and remission with desvenlafaxine 50 mg and 100 mg: a pooled analysis of randomized, placebo-controlled studies in patients with major depressive disorderClaudio N Soares, Dalia B Wajsbrot, Matthieu Boucher
European Journal of Pharmacology|July 14, 2004
Alterations of beta-adrenoceptor responsiveness in postischemic myocardium after 72 h of reperfusionMatthieu Boucher, Satra Nim, Chantal de Montigny, et al.
BMC Psychiatry|November 13, 2024
Long-term effectiveness of aripiprazole once monthly on functioning and quality of life in schizophrenia: results of year 2 of the ReLiAM studyMarc-André Roy, François Therrien, Matthieu Boucher, et al.
BMC Psychiatry|December 9, 2022
Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use - a post hoc analysis of the ReLiAM studyHoward C Margolese, Matthieu Boucher, Francois Therrien, et al.
Journal of Cardiac Failure|July 3, 2007
Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapySven T Pleger, Matthieu Boucher, Patrick Most, et al.
International Journal of Psychiatry in Clinical Practice|February 9, 2019
Switching medication products during the treatment of psychiatric illnessPierre Blier, Howard C Margolese, E Adriana Wilson, et al.
Journal of Psychopharmacology (Oxford, England)|January 9, 2020
Effects of desvenlafaxine versus placebo on MDD symptom clusters: A pooled analysisMartin A Katzman, Xuemei Wang, Dalia B Wajsbrot, et al.
Pageof 5